|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
9 January 2023 |
|
Main ID: |
NCT02353585 |
|
Date of registration:
|
28/01/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Novel Oral Anticoagulants in Stroke Patients
NOACISP |
|
Scientific title:
|
A Registry of Novel Oral AntiCoagulants and Vitamin K-antagonists In Stroke Patients - a Multi-center Audit Addressing a) Intracerebral Haemorrhage and b) Acute Ischemic Stroke in Patients Treated With Oral Anticoagulants |
|
Date of first enrolment:
|
December 2014 |
|
Target sample size:
|
1050 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02353585 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Philippe Lyrer, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Neurology and Stroke Center |
|
|
Name:
|
Stefan Engelter, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Neurology and Stroke Center |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with ICH occurring while under treatment with NOACs (last intake <48 hours)
or VKAs for any indication;
- Patients with acute ischaemic stroke occurring while under treatment with NOACs (last
intake <48 hours) or VKAs for any indication.
Exclusion Criteria:
- The patient is, in the opinion of the investigator, unlikely to comply with the
clinical study protocol or is unsuitable for any other reason.
- Patients <18 years of age
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Intracranial Hemorrhages
|
|
Ischemic Stroke
|
|
Primary Outcome(s)
|
|
Functional neurological outcome
[Time Frame: 3 month]
|
|
Secondary Outcome(s)
|
|
symptomatic intracranial hemorrhage
[Time Frame: 7 days]
|
|
Hematoma expansion
[Time Frame: 0-48 hours]
|
|
Secondary ID(s)
|
|
EKNZ: 2014-027
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|